FDA Clearance Tracker · K252360
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
Last checked: Nov 19, 2026Latest source record: Mar 28, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2026
Substantially Equivalent
Time to decision
242 days
Received Jul 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K252360
- Device name
- ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
- Applicant
- Anumana, Inc.
- Applicant location
- Cambridge, MA
- Received
- Jul 29, 2025
- Decided
- Mar 28, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2380
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code SAT. The earliest in FDA's data is K233666, decided Apr 5, 2024.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K252360
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Anumana, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- WatchMate Software510(k)
K260300 · Decided Jun 15, 2026 · 136 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
- ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)Breakthrough510(k)
K253801 · Decided Apr 7, 2026 · 130 days after receipt
Device type: Cardiac Amyloidosis Machine Learning-Based Notification Software (SHP) · Cardiology
K250652 · Decided Jul 28, 2025 · 146 days after receipt
Device type: Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.